BioCryst Pharmaceuticals Inc Free Cash Flow Generation Index

Latest as of December 2025: 1.00x

BioCryst Pharmaceuticals Inc free cash flow generation index. BioCryst Pharmaceuticals Inc (BCRX) has a Free Cash Flow Generation Index of 1.00x as of December 2025. Free cash flow of $275.23 Million represents 1% of operating cash flow ($276.04 Million).

FCF Generation Index

1.00x

Free Cash Flow / Operating CF

Free Cash Flow

$275.23 Million

USD

Operating Cash Flow

$276.04 Million

USD

Capital Expenditures

$802.00K

USD

Free Cash Flow Generation Index of BioCryst Pharmaceuticals Inc (2025–2025)

Free cash flow generation index of BioCryst Pharmaceuticals Inc from 2025 to 2025. Historical FCF Generation Index trend for BioCryst Pharmaceuticals Inc across 1 annual periods. See BioCryst Pharmaceuticals Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.

BioCryst Pharmaceuticals Inc Free Cash Flow Generation Index by Year (2025–2025)

BioCryst Pharmaceuticals Inc free cash flow generation index by year from 2025 to 2025. Year-by-year Free Cash Flow Generation Index for BioCryst Pharmaceuticals Inc. For the full cash flow conversion analysis, see BCRX cash generation efficiency.

Year	FCG Index	Free Cash Flow (USD)	Operating CF	Capital Expenditures	YoY Change
2025	0.99x	$327.41 Million	$329.88 Million	$2.47 Million	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).